| Center for Drug Evaluation and Research | 1260.1 |
| Office of the Center Director | 1261.1 |
| Office of Regulatory Policy | 1260.2 |
| Division of Regulatory Policy I | 1260.21 |
| Division of Regulatory Policy II | 1260.22 |
| Division of Information Disclosure Policy | 1260.23 |
| Division of Regulatory Policy III | 1260.24 |
| Division of Regulatory Policy IV | 1260.25 |
| Office of Management | 1261.10 |
| Division of Budget and Resource Management | 1261.11 |
| Division of Management Services | 1261.17 |
| Division of User Fee Management | 1261.18 |
| Office of Communications | 1261.20 |
| Division of Digital and Online Communications | 1261.22 |
| Division of Health Communication | 1261.25 |
| Division of Drug Information | 1261.26 |
| Office of Surveillance and Epidemiology | 1261.5 |
| Office of Medication Error Prevention and Risk Management | 1261.57 |
| Division of Medication Error Prevention and Analysis I | 1261.571 |
| Division of Risk Management | 1261.572 |
| Division of Medication Error Prevention and Analysis II | 1261.573 |
| Division of Mitigation Assessment and Medication Error Surveillance | 1261.574 |
| Office of Pharmacovigilance and Epidemiology | 1261.58 |
| Division of Epidemiology I | 1261.581 |
| Division of Epidemiology II | 1261.582 |
| Division of Pharmacovigilance I | 1261.583 |
| Division of Pharmacovigilance II | 1261.584 |
| Office of Compliance | 1262.1 |
| Office of Unapproved Drugs and Labeling Compliance | 1262.3 |
| Division of Compounded Drugs | 1262.31 |
| Division of Unapproved Drugs and Labeling | 1262.32 |
| Division of Labeling, Registration and Unapproved Drugs | 1262.33 |
| Office of Manufacturing Quality | 1262.4 |
| Division of Drug Quality I | 1262.45 |
| Division of Drug Quality II | 1262.46 |
| Division of Drug Quality III | 1262.47 |
| Office of Scientific Investigations | 1262.5 |
| Division of Good Clinical Practice Compliance | 1262.52 |
| Division of Safety Compliance | 1262.53 |
| Division of Enforcement and Postmarket Safety | 1262.54 |
| Division of Clinical Compliance Evaluation | 1262.55 |
| Office of Drug Security, Integrity and Response | 1262.6 |
| Division of Global Drug Distribution and Policy | 1262.61 |
| Division of Supply Chain Integrity | 1262.62 |
| Office of Program and Regulatory Operations | 1262.7 |
| Office of Compounding Quality and Compliance | 1262.8 |
| Division of Compounding I | 1262.81 |
| Division of Compounding II | 1262.82 |
| Division of Compounding Policy and Outreach | 1262.83 |
| Office of New Drugs | 1263.1 |
| Office of Administrative Operations | 1263.11a |
| Office of Nonprescription Drugs | 1263.12a |
| Division of Nonprescription Drugs I | 1263.121 |
| Division of Nonprescription Drugs II | 1263.122 |
| Office of Specialty Medicine | 1263.13a |
| Division of Ophthalmology | 1263.131 |
| Division of Imaging & Radiation Medicine | 1263.132 |
| Office of New Drug Policy | 1263.14a |
| Division of Clinical Policy | 1263.141 |
| Division of Regulatory Policy | 1263.142 |
| Office of Regulatory Operations | 1263.15a |
| Division of Regulatory Operations for Infectious Disease | 1263.151 |
| Division of Regulatory Operations for Oncologic Disease | 1263.152 |
| Division of Regulatory Operations for Nonprescription Drugs | 1263.153 |
| Division of Regulatory Operations for Neuroscience | 1263.154 |
| Division of Regulatory Operations for Cardiology, Hematology, Endocrinology & Nephrology | 1263.155 |
| Division of Regulatory Operations for Immunology & Inflammation | 1263.156 |
| Division of Regulatory Operations for Rare Diseases, Pediatrics, Urology & Reproductive Medicine | 1263.157 |
| Division of Regulatory Operations for Specialty Medicine | 1263.158 |
| Office of Program Operations | 1263.16a |
| Office of Drug Evaluation Science | 1263.17a |
| Division of Clinical Outcome Assessment | 1263.171 |
| Division of Biomedical Informatics, Research & Biomarker Development | 1263.172 |
| Office of Neuroscience | 1263.20 |
| Division of Neurology I | 1263.21a |
| Division of Neurology II | 1263.24a |
| Division of Psychiatry | 1263.25 |
| Division of Anesthesiology, Addiction Medicine & Pain Medicine | 1263.26 |
| Division of Pharmacology Toxicology for Neuroscience | 1263.27 |
| Office of Cardiology, Hematology, Endocrinology & Nephrology | 1263.30 |
| Division of Diabetes, Lipid Disorders & Obesity | 1263.31 |
| Division of General Endocrinology | 1263.32 |
| Division of Cardiology & Nephrology | 1263.35 |
| Division of Non-Malignant Hematology | 1263.36 |
| Division of Pharmacology Toxicology for Cardiology, Hematology, Endocrinology & Nephrology | 1263.37 |
| Office of Immunology & Inflammation | 1263.40 |
| Division of Gastroenterology | 1263.42 |
| Division of Dermatology & Dentistry | 1263.45 |
| Division of Rheumatology & Transplant Medicine | 1263.46 |
| Division of Pulmonology, Allergy & Critical Care | 1263.47 |
| Division of Hepatology & Nutrition | 1263.48 |
| Division of Pharmacology Toxicology for Immunology & Inflammation | 1263.49 |
| Office of Infectious Diseases | 1263.50 |
| Division of Anti-Infectives | 1263.51 |
| Division of Antivirals | 1263.52 |
| Division of Pharmacology Toxicology for Infectious Diseases | 1263.53a |
| Office of Rare Diseases, Pediatrics, Urology & Reproductive Medicine | 1263.60 |
| Division of Pharmacology Toxicology for Rare Diseases, Pediatrics, Urology & Reproductive Medicine | 1263.61a |
| Division of Rare Diseases & Medical Genetics | 1263.62a |
| Division of Urology, Obstetrics, & Gynecology | 1263.63a |
| Division of Pediatric & Maternal Health | 1263.67 |
| Office of Oncologic Diseases | 1263.70 |
| Division of Oncology I | 1263.74 |
| Division of Hematologic Malignancies I | 1263.75 |
| Division of Oncology II | 1263.76 |
| Division of Hematology Oncology Toxicology | 1263.77 |
| Division of Oncology III | 1263.79 |
| Division of Hematologic Malignancies II | 1263.80 |
| Office of Therapeutic Biologics and Biosimilars | 1263.90 |
| Office of Medical Policy | 1266.1 |
| Office of Prescription Drug Promotion | 1266.11 |
| Division of Advertising and Promotion Review II | 1266.111 |
| Division of Advertising and Promotion Review I | 1266.112 |
| Office of Medical Policy Initiatives | 1266.12 |
| Division of Medical Policy Development | 1266.121 |
| Division of Medical Policy Programs | 1266.122 |
| Division of Clinical Trial Quality | 1266.123 |
| Office of Executive Programs | 1267.1 |
| Division of Learning and Organizational Development | 1267.11 |
| Division of Advisory Committee and Consultant Management | 1267.13 |
| Office of Translational Sciences | 1268.1 |
| Office of Biostatistics | 1268.3 |
| Division of Analytics and Informatics | 1268.30 |
| Division of Biometrics I | 1268.31 |
| Division of Biometrics II | 1268.32 |
| Division of Biometrics III | 1268.33 |
| Division of Biometrics IV | 1268.34 |
| Division of Biometrics V | 1268.35 |
| Division of Biometrics VI | 1268.36 |
| Division of Biometrics VII | 1268.37 |
| Division of Biometrics VIII | 1268.38 |
| Division of Biometrics IX | 1268.39 |
| Office of Clinical Pharmacology | 1268.4 |
| Division of Neuropsychiatric Pharmacology | 1268.41 |
| Division of Inflammation & Immune Pharmacology | 1268.42 |
| Division of Cardiometabolic & Endocrine Pharmacology | 1268.43 |
| Division of Infectious Disease Pharmacology | 1268.44 |
| Division of Cancer Pharmacology I | 1268.45 |
| Division of Pharmacometrics | 1268.46 |
| Division of Applied Regulatory Science | 1268.47 |
| Division of Cancer Pharmacology II | 1268.48 |
| Division of Translational & Precision Medicine | 1268.49 |
| Office of Computational Science | 1268.5 |
| Division of Regulatory Review & Research | 1268.51 |
| Division of Tools, Technology & Innovation | 1268.52 |
| Office of Study Integrity and Surveillance | 1268.6a |
| Division of New Drug Study Integrity | 1268.61 |
| Division of Generic Drug Study Integrity | 1268.62 |
| Office of Administrative Operations | 1268.7 |
| Office of Strategic Programs | 1270.2 |
| Office of Program and Strategic Analysis | 1270.21 |
| Office of Business Informatics | 1270.22 |
| Division of Drug Quality and Compliance Services Solution | 1270.222 |
| Division of Data Management Services and Solutions | 1270.223 |
| Division of Business Management Services and Solutions | 1270.224 |
| Division of Regulatory Review and Drug Safety Services Solutions | 1270.225 |
| Office of Pharmaceutical Quality | 1280.1a |
| Office of Administrative Operations | 1280.11 |
| Office of Quality Assurance | 1280.12 |
| Office of Product Quality Assessment III | 1280.20a |
| Division of Product Quality Assessment XIII | 1280.21a |
| Division of Product Quality Assessment XIV | 1280.22a |
| Division of Product Quality Assessment XV | 1280.23a |
| Division of Product Quality Assessment XVI | 1280.24a |
| Division of Product Quality Assessment XVII | 1280.25 |
| Division of Product Quality Assessment XVIII | 1280.26 |
| Division of Product Quality Assessment XIX | 1280.27 |
| Office of Product Quality Assessment II | 1280.30a |
| Division of Product Quality Assessment VII | 1280.33a |
| Division of Product Quality Assessment VIII | 1280.34a |
| Division of Product Quality Assessment IX | 1280.35a |
| Division of Product Quality Assessment X | 1280.36a |
| Division of Product Quality Assessment XI | 1280.37 |
| Division of Product Quality Assessment XII | 1280.38 |
| Office of Policy for Pharmaceutical Quality | 1280.40 |
| Division of Regulations and Guidance | 1280.41 |
| Division of Internal Policy and Communication | 1280.42 |
| Division of Editorial and Project Management | 1280.43 |
| Office of Pharmaceutical Manufacturing Assessment | 1280.50 |
| Division of Pharmaceutical Manufacturing Assessment I | 1280.51 |
| Division of Pharmaceutical Manufacturing Assessment II | 1280.52 |
| Division of Pharmaceutical Manufacturing Assessment III | 1280.53 |
| Division of Pharmaceutical Manufacturing Assessment IV | 1280.54a |
| Division of Pharmaceutical Manufacturing Assessment V | 1280.55b |
| Division of Pharmaceutical Manufacturing Assessment VI | 1280.57a |
| Office of Quality Surveillance | 1280.60 |
| Division of Quality Intelligence I | 1280.62 |
| Division of Quality Intelligence II | 1280.63 |
| Division of Quality Intelligence III | 1280.64 |
| Office of Pharmaceutical Quality Research | 1280.70a |
| Division of Pharmaceutical Quality Research I | 1280.71a |
| Division of Pharmaceutical Quality Research II | 1280.72a |
| Division of Pharmaceutical Quality Research III | 1280.73a |
| Division of Pharmaceutical Quality Research IV | 1280.74 |
| Division of Pharmaceutical Quality Research V | 1280.75 |
| Division of Pharmaceutical Quality Research VI | 1280.76 |
| Office of Program Regulatory Operations | 1280.80 |
| Division of Regulatory and Business Process Management I | 1280.81 |
| Division of Regulatory and Business Process Management II | 1280.82 |
| Division of Regulatory and Business Process Management III | 1280.83a |
| Division of Regulatory and Business Process Management IV | 1280.85 |
| Office of Product Quality Assessment I | 1280.90a |
| Division of Product Quality Assessment I | 1280.91a |
| Division of Product Quality Assessment II | 1280.92a |
| Division of Product Quality Assessment III | 1280.93a |
| Division of Product Quality Assessment IV | 1280.94a |
| Division of Product Quality Assessment V | 1280.95b |
| Division of Product Quality Assessment VI | 1280.96b |
| Office of Generic Drugs | 1290.1a |
| Office of Research and Standards | 1291.1a |
| Division of Therapeutic Performance I | 1291.11 |
| Division of Quantitative Methods and Modeling | 1291.12 |
| Division of Therapeutic Performance II | 1291.13 |
| Office of Bioequivalence | 1292.1a |
| Division of Bioequivalence I | 1292.11 |
| Division of Bioequivalence II | 1292.12 |
| Division of Bioequivalence III | 1292.13 |
| Division of Bioequivalence Process Management | 1292.15 |
| Office of Generic Drug Policy | 1293.1a |
| Division of Legal and Regulatory Support | 1293.11 |
| Division of Policy Development | 1293.12 |
| Division of Orange Book Publication and Regulatory Assessment | 1293.13 |
| Office of Regulatory Operations | 1294.1a |
| Division of Labeling Review | 1294.11 |
| Division of Filing Review | 1294.12 |
| Division of Project Management | 1294.13 |
| Division of Quality Management Systems | 1294.14 |
| Office of Safety and Clinical Evaluation | 1295.1 |
| Division of Clinical Review | 1295.11 |
| Division of Pharmacology Toxicology Review | 1295.12 |
| Division of Clinical Safety and Surveillance | 1295.13 |